Cargando…
Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant
The relative bioavailability of nicotine from a nasal spray was assessed in 15 smokers suffering a common cold and rhinitis according to generally accepted criteria. The patients were given a single dose of 2 mg nicotine from the nasal spray with and without concurrent administration of a nasal vaso...
Autores principales: | Lunell, E., Molander, L., Andersson, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087527/ https://www.ncbi.nlm.nih.gov/pubmed/7542589 http://dx.doi.org/10.1007/BF00202176 |
Ejemplares similares
-
Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays
por: Mösges, Ralph, et al.
Publicado: (2017) -
Treating acute rhinitis and exacerbations of chronic rhinitis – A role for topical decongestants?
por: Green, Robin J., et al.
Publicado: (2020) -
First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases
por: Helmer, Eric, et al.
Publicado: (2017) -
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers
por: Tylleskar, Ida, et al.
Publicado: (2021) -
Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults
por: Hakkarainen, Katja M, et al.
Publicado: (2014)